Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank James

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of the American College of Radiology : JACR|October 4, 2011
White paper from the ACR Task Force on Print Media in RadiologyRichard Duszak, G Rebecca Haines, Vanessa Van Duyn Wear, et al.
Chronic Diseases and Translational Medicine|June 8, 2026
GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular OutcomesGabriel Amorim Moreira Alves, Masatoki Teranishi, Rajendranandini Majumdar, et al.
Frontiers in Immunology|January 24, 2022
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant MelanomaRahul C Khanolkar, Chu Zhang, Farah Al-Fatyan, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of the American College of Radiology : JACR|October 4, 2011
White paper from the ACR Task Force on Print Media in RadiologyRichard Duszak, G Rebecca Haines, Vanessa Van Duyn Wear, et al.
Chronic Diseases and Translational Medicine|June 8, 2026
GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular OutcomesGabriel Amorim Moreira Alves, Masatoki Teranishi, Rajendranandini Majumdar, et al.
Frontiers in Immunology|January 24, 2022
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant MelanomaRahul C Khanolkar, Chu Zhang, Farah Al-Fatyan, et al.
Pageof 7